Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Scientific Reports|June 1, 2019
Gray Matter Alterations in Early and Late Relapsing-Remitting Multiple Sclerosis Evaluated with Synthetic Quantitative Magnetic Resonance ImagingChristina Andica, Akifumi Hagiwara, Koji Kamagata, et al.Biological Psychiatry|September 1, 2004
No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter studyHiroshi Kunugi, Yoshimi Iijima, Masahiko Tatsumi, et al.Clinical and Experimental Immunology|July 7, 2026
Helios expression in naïve CD4+ T cells decreases from neonates to older adultsHiroshi Mutoh, Takeo Mukai, Atsushi Ito, et al.Translational Oncology|February 10, 2017
De Novo Emergence of Mesenchymal Stem-Like CD105+ Cancer Cells by Cytotoxic Agents in Human Hepatocellular CarcinomaYoshimoto Nomura, Taro Yamashita, Naoki Oishi, et al.Journal of Pediatric Surgery|April 19, 2011
Papillary carcinoma with extensive squamous metaplasia arising from thyroglossal duct cyst in an 11-year-old girl: significance of differentiation from squamous cell carcinoma: a case reportKiyoshi Gomi, Norihiko Kitagawa, Yoshiko Usui, et al.Magnetic Resonance Imaging|April 15, 2014
Multiple sclerosis: Benefits of q-space imaging in evaluation of normal-appearing and periplaque white matterMasaaki Hori, Mariko Yoshida, Kazumasa Yokoyama, et al.Cancer Cell International|October 28, 2017
Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinomaTakehiro Hayashi, Taro Yamashita, Hikari Okada, et al.Radiation Medicine|June 9, 2005
Quantitative evaluation of the pyramidal tract segmented by diffusion tensor tractography: feasibility study in patients with amyotrophic lateral sclerosisShigeki Aoki, Nobue K Iwata, Yoshitaka Masutani, et al.Journal of Hepatology|June 23, 2015
Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinomaKouki Nio, Taro Yamashita, Hikari Okada, et al.Anticancer Research|March 10, 2015
TSU-68 ameliorates hepatocellular carcinoma growth by inhibiting microenvironmental platelet-derived growth factor signalingYasumasa Hara, Taro Yamashita, Naoki Oishi, et al.Pageof 9